ID   CD209_HUMAN             Reviewed;         404 AA.
AC   Q9NNX6; A8KAM4; A8MVQ9; G5E9C4; Q2TB19; Q96QP7; Q96QP8; Q96QP9;
AC   Q96QQ0; Q96QQ1; Q96QQ2; Q96QQ3; Q96QQ4; Q96QQ5; Q96QQ6; Q96QQ7;
AC   Q96QQ8;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-JUL-2015, entry version 142.
DE   RecName: Full=CD209 antigen;
DE   AltName: Full=C-type lectin domain family 4 member L;
DE   AltName: Full=Dendritic cell-specific ICAM-3-grabbing non-integrin 1;
DE            Short=DC-SIGN;
DE            Short=DC-SIGN1;
DE   AltName: CD_antigen=CD209;
GN   Name=CD209; Synonyms=CLEC4L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH HIV-1 GP120.
RC   TISSUE=Placenta;
RX   PubMed=1518869; DOI=10.1073/pnas.89.17.8356;
RA   Curtis B.M., Scharnowske S., Watson A.J.;
RT   "Sequence and expression of a membrane-associated C-type lectin that
RT   exhibits CD4-independent binding of human immunodeficiency virus
RT   envelope glycoprotein gp 120.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:8356-8360(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=10975799; DOI=10.4049/jimmunol.165.6.2937;
RA   Soilleux E.J., Barten R., Trowsdale J.;
RT   "DC-SIGN, a related gene, DC-SIGNR, and CD23 form a cluster on
RT   19p13.";
RL   J. Immunol. 165:2937-2942(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=11257134; DOI=10.1084/jem.193.6.671;
RA   Bashirova A.A., Geijtenbeek T.B.H., van Duijnhoven G.C.F.,
RA   van Vliet S.J., Eilering J.B.G., Martin M.P., Wu L., Martin T.D.,
RA   Viebig N., Knolle P.A., Kewalramani V.N., van Kooyk Y., Carrington M.;
RT   "A dendritic cell-specific intercellular adhesion molecule 3-grabbing
RT   nonintegrin (DC-SIGN)-related protein is highly expressed on human
RT   liver sinusoidal endothelial cells and promotes HIV-1 infection.";
RL   J. Exp. Med. 193:671-678(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5; 6; 7; 8; 9; 10; 11
RP   AND 12), ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=11337487; DOI=10.1074/jbc.M009807200;
RA   Mummidi S., Catano G., Lam L., Hoefle A., Telles V., Begum K.,
RA   Jimenez F., Ahuja S.S., Ahuja S.K.;
RT   "Extensive repertoire of membrane-bound and soluble dendritic cell-
RT   specific ICAM-3-grabbing nonintegrin 1 (DC-SIGN1) and DC-SIGN2
RT   isoforms. Inter-individual variation in expression of DC-SIGN
RT   transcripts.";
RL   J. Biol. Chem. 276:33196-33212(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 10).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH ICAM3.
RX   PubMed=10721995; DOI=10.1016/S0092-8674(00)80694-7;
RA   Geijtenbeek T.B.H., Kwon D.S., Torensma R., van Vliet S.J.,
RA   van Duijnhoven G.C.F., Middel J., Cornelissen I.L., Nottet H.S.,
RA   Kewalramani V.N., Littman D.R., Figdor C.G., van Kooyk Y.;
RT   "DC-SIGN, a dendritic cell-specific HIV-1-binding protein that
RT   enhances trans-infection of T cells.";
RL   Cell 100:587-597(2000).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH ICAM2.
RX   PubMed=11017109; DOI=10.1038/79815;
RA   Geijtenbeek T.B.H., Krooshoop D.J., Bleijs D.A., van Vliet S.J.,
RA   van Duijnhoven G.C.F., Grabovsky V., Alon R., Figdor C.G.,
RA   van Kooyk Y.;
RT   "DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking.";
RL   Nat. Immunol. 1:353-357(2000).
RN   [11]
RP   SUBUNIT, AND LIGAND-BINDING.
RX   PubMed=11384997; DOI=10.1074/jbc.M104565200;
RA   Mitchell D.A., Fadden A.J., Drickamer K.;
RT   "A novel mechanism of carbohydrate recognition by the C-type lectins
RT   DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent
RT   ligands.";
RL   J. Biol. Chem. 276:28939-28945(2001).
RN   [12]
RP   INTERACTION WITH CYTOMEGALOVIRUS GLYCOPROTEIN B (GB).
RX   PubMed=12433371; DOI=10.1016/S1074-7613(02)00447-8;
RA   Halary F., Amara A., Lortat-Jacob H., Messerle M., Delaunay T.,
RA   Houles C., Fieschi F., Arenzana-Seisdedos F., Moreau J.-F.,
RA   Dechanet-Merville J.;
RT   "Human cytomegalovirus binding to DC-SIGN is required for dendritic
RT   cell infection and target cell trans-infection.";
RL   Immunity 17:653-664(2002).
RN   [13]
RP   INTERACTION WITH ICAM 3 AND HIV-1 GP120, AND MUTAGENESIS OF ASP-320;
RP   GLU-324; GLU-347; ASN-349; ASN-350; ASP-355; ASN-365 AND ASP-366.
RX   PubMed=11799126; DOI=10.1074/jbc.M111532200;
RA   Geijtenbeek T.B.H., van Duijnhoven G.C.F., van Vliet S.J., Krieger E.,
RA   Vriend G., Figdor C.G., van Kooyk Y.;
RT   "Identification of different binding sites in the dendritic cell-
RT   specific receptor DC-SIGN for intercellular adhesion molecule 3 and
RT   HIV-1.";
RL   J. Biol. Chem. 277:11314-11320(2002).
RN   [14]
RP   FUNCTION, AND MUTAGENESIS OF 14-LEU-LEU-15.
RX   PubMed=11859097; DOI=10.4049/jimmunol.168.5.2118;
RA   Engering A., Geijtenbeek T.B.H., van Vliet S.J., Wijers M.,
RA   van Liempt E., Demaurex N., Lanzavecchia A., Fransen J., Figdor C.G.,
RA   Piguet V., van Kooyk Y.;
RT   "The dendritic cell-specific adhesion receptor DC-SIGN internalizes
RT   antigen for presentation to T cells.";
RL   J. Immunol. 168:2118-2126(2002).
RN   [15]
RP   ROLE IN HIV-1 INFECTION.
RX   PubMed=11825572; DOI=10.1016/S1074-7613(02)00259-5;
RA   Kwon D.S., Gregorio G., Bitton N., Hendrickson W.A., Littman D.R.;
RT   "DC-SIGN-mediated internalization of HIV is required for trans-
RT   enhancement of T cell infection.";
RL   Immunity 16:135-144(2002).
RN   [16]
RP   INTERACTION WITH HIV-1 GP120; HIV-2 GP120; SIV GP120 AND EBOLA
RP   GLYCOPROTEINS.
RX   PubMed=12502850; DOI=10.1128/JVI.77.2.1337-1346.2003;
RA   Lin G., Simmons G., Poehlmann S., Baribaud F., Ni H., Leslie G.J.,
RA   Haggarty B.S., Bates P., Weissman D., Hoxie J.A., Doms R.W.;
RT   "Differential N-linked glycosylation of human immunodeficiency virus
RT   and Ebola virus envelope glycoproteins modulates interactions with DC-
RT   SIGN and DC-SIGNR.";
RL   J. Virol. 77:1337-1346(2003).
RN   [17]
RP   FUNCTION IN HIV-1 INFECTION.
RX   PubMed=12692233; DOI=10.1128/JVI.77.9.5313-5323.2003;
RA   Nobile C., Moris A., Porrot F., Sol-Foulon N., Schwartz O.;
RT   "Inhibition of human immunodeficiency virus type 1 Env-mediated fusion
RT   by DC-SIGN.";
RL   J. Virol. 77:5313-5323(2003).
RN   [18]
RP   FUNCTION.
RX   PubMed=12574325; DOI=10.4049/jimmunol.170.4.1635;
RA   Appelmelk B.J., van Die I., van Vliet S.J., Vandenbroucke-Grauls C.M.,
RA   Geijtenbeek T.B.H., van Kooyk Y.;
RT   "Carbohydrate profiling identifies new pathogens that interact with
RT   dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic
RT   cells.";
RL   J. Immunol. 170:1635-1639(2003).
RN   [19]
RP   REVIEW ON ROLE IN HIV-1 INFECTION AND ON PATHOGEN BINDING.
RX   PubMed=12949494; DOI=10.1038/nri1182;
RA   van Kooyk Y., Geijtenbeek T.B.H.;
RT   "DC-SIGN: escape mechanism for pathogens.";
RL   Nat. Rev. Immunol. 3:697-709(2003).
RN   [20]
RP   REVIEW ON ROLE IN HIV-1 INFECTION.
RX   PubMed=12960229; DOI=10.1189/jlb.0503208;
RA   Turville S., Wilkinson J., Cameron P., Dable J., Cunningham A.L.;
RT   "The role of dendritic cell C-type lectin receptors in HIV
RT   pathogenesis.";
RL   J. Leukoc. Biol. 74:710-718(2003).
RN   [21]
RP   INTERACTION WITH HCV E2 GLYCOPROTEIN.
RX   PubMed=15371595; DOI=10.1073/pnas.0405695101;
RA   Cormier E.G., Durso R.J., Tsamis F., Boussemart L., Manix C.,
RA   Olson W.C., Gardner J.P., Dragic T.;
RT   "L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver
RT   cells by hepatitis C virus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:14067-14072(2004).
RN   [22]
RP   POLYMORPHISM, AND INVOLVEMENT IN SUSCEPTIBILITY TO DENGUE VIRUS
RP   INFECTION.
RX   PubMed=15838506; DOI=10.1038/ng1550;
RA   Sakuntabhai A., Turbpaiboon C., Casademont I., Chuansumrit A.,
RA   Lowhnoo T., Kajaste-Rudnitski A., Kalayanarooj S.M.,
RA   Tangnararatchakit K., Tangthawornchaikul N., Vasanawathana S.,
RA   Chaiyaratana W., Yenchitsomanus P.T., Suriyaphol P., Avirutnan P.,
RA   Chokephaibulkit K., Matsuda F., Yoksan S., Jacob Y., Lathrop G.M.,
RA   Malasit P., Despres P., Julier C.;
RT   "A variant in the CD209 promoter is associated with severity of dengue
RT   disease.";
RL   Nat. Genet. 37:507-513(2005).
RN   [23]
RP   INTERACTION WITH C1QBP.
RX   PubMed=22700724; DOI=10.1182/blood-2011-07-369728;
RA   Hosszu K.K., Valentino A., Vinayagasundaram U., Vinayagasundaram R.,
RA   Joyce M.G., Ji Y., Peerschke E.I., Ghebrehiwet B.;
RT   "DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the
RT   surface of monocyte-derived immature dendritic cells.";
RL   Blood 120:1228-1236(2012).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 254-382 IN COMPLEX WITH
RP   GLCNAC(2)-MAN(3) PENTASACCHARIDE.
RX   PubMed=11739956; DOI=10.1126/science.1066371;
RA   Feinberg H., Mitchell D.A., Drickamer K., Weis W.I.;
RT   "Structural basis for selective recognition of oligosaccharides by DC-
RT   SIGN and DC-SIGNR.";
RL   Science 294:2163-2166(2001).
RN   [25]
RP   INVOLVEMENT IN MYCOBACTERIUM TUBERCULOSIS SUSCEPTIBILITY.
RX   PubMed=16379498; DOI=10.1371/journal.pmed.0030020;
RA   Barreiro L.B., Neyrolles O., Babb C.L., Tailleux L., Quach H.,
RA   McElreavey K., Helden P.D., Hoal E.G., Gicquel B., Quintana-Murci L.;
RT   "Promoter variation in the DC-SIGN-encoding gene CD209 is associated
RT   with tuberculosis.";
RL   PLoS Med. 3:230-235(2006).
CC   -!- FUNCTION: Pathogen-recognition receptor expressed on the surface
CC       of immature dendritic cells (DCs) and involved in initiation of
CC       primary immune response. Thought to mediate the endocytosis of
CC       pathogens which are subsequently degraded in lysosomal
CC       compartments. The receptor returns to the cell membrane surface
CC       and the pathogen-derived antigens are presented to resting T-cells
CC       via MHC class II proteins to initiate the adaptive immune
CC       response. Probably recognizes in a calcium-dependent manner high
CC       mannose N-linked oligosaccharides in a variety of pathogen
CC       antigens, including HIV-1 gp120, HIV-2 gp120, SIV gp120,
CC       ebolavirus glycoproteins, cytomegalovirus gB, HCV E2, dengue virus
CC       gE, Leishmania pifanoi LPG, Lewis-x antigen in Helicobacter pylori
CC       LPS, mannose in Klebsiella pneumonae LPS, di-mannose and tri-
CC       mannose in Mycobacterium tuberculosis ManLAM and Lewis-x antigen
CC       in Schistosoma mansoni SEA.
CC   -!- FUNCTION: On DCs it is a high affinity receptor for ICAM2 and
CC       ICAM3 by binding to mannose-like carbohydrates. May act as a DC
CC       rolling receptor that mediates transendothelial migration of DC
CC       presursors from blood to tissues by binding endothelial ICAM2.
CC       Seems to regulate DC-induced T-cell proliferation by binding to
CC       ICAM3 on T-cells in the immunological synapse formed between DC
CC       and T-cells.
CC   -!- SUBUNIT: Homotetramer. Binds to many viral surface glycoproteins
CC       such as HIV-1 gp120, HIV-2 gp120, SIV gp120, ebolavirus envelope
CC       glycoproteins, cytomegalovirus gB, HCV E2 and dengue virus major
CC       envelope protein E. Interacts with C1QBP; the interaction is
CC       indicative for a C1q:C1QBP:CD209 signaling complex.
CC       {ECO:0000269|PubMed:10721995, ECO:0000269|PubMed:11017109,
CC       ECO:0000269|PubMed:11384997, ECO:0000269|PubMed:11739956,
CC       ECO:0000269|PubMed:11799126, ECO:0000269|PubMed:12433371,
CC       ECO:0000269|PubMed:12502850, ECO:0000269|PubMed:1518869,
CC       ECO:0000269|PubMed:15371595, ECO:0000269|PubMed:22700724}.
CC   -!- INTERACTION:
CC       Q03463:- (xeno); NbExp=2; IntAct=EBI-9257341, EBI-9257330;
CC       Q08AM6:VAC14; NbExp=3; IntAct=EBI-9257341, EBI-2107455;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cell membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Cell membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Cell membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 5: Cell membrane {ECO:0000305};
CC       Single-pass type II membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 6: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 7: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 8: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 9: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 10: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 11: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 12: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=12;
CC         Comment=Additional isoforms seem to exist. Several splicing
CC         events may be used independently in a modular way. Deletion of
CC         the transmembrane domain encoding exon through alternative
CC         splicing produces soluble isoforms.
CC         {ECO:0000269|PubMed:11337487};
CC       Name=1; Synonyms=mDC-SIGN1A type I;
CC         IsoId=Q9NNX6-1; Sequence=Displayed;
CC       Name=2; Synonyms=mDC-SIGN1A type II;
CC         IsoId=Q9NNX6-2; Sequence=VSP_010049;
CC       Name=3; Synonyms=mDC-SIGN1A type III;
CC         IsoId=Q9NNX6-3; Sequence=VSP_010044;
CC       Name=4; Synonyms=mDC-SIGN1A type IV;
CC         IsoId=Q9NNX6-4; Sequence=VSP_010042;
CC       Name=5; Synonyms=mDC-SIGN1B type I;
CC         IsoId=Q9NNX6-5; Sequence=VSP_010037;
CC       Name=6; Synonyms=sDC-SIGN1A type I;
CC         IsoId=Q9NNX6-6; Sequence=VSP_010041;
CC       Name=7; Synonyms=sDC-SIGN1A type II;
CC         IsoId=Q9NNX6-7; Sequence=VSP_010038;
CC       Name=8; Synonyms=sDC-SIGN1A type III;
CC         IsoId=Q9NNX6-8; Sequence=VSP_010038, VSP_010043;
CC       Name=9; Synonyms=sDC-SIGN1A type IV;
CC         IsoId=Q9NNX6-9; Sequence=VSP_010039, VSP_010040;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=10; Synonyms=sDC-SIGN1B type I;
CC         IsoId=Q9NNX6-10; Sequence=VSP_010037, VSP_010041;
CC       Name=11; Synonyms=sDC-SIGN1B type II;
CC         IsoId=Q9NNX6-11; Sequence=VSP_010037, VSP_010041, VSP_010047;
CC       Name=12; Synonyms=sDC-SIGN1B type III;
CC         IsoId=Q9NNX6-12; Sequence=VSP_010037, VSP_010041, VSP_010048,
CC                                   VSP_010050;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in dendritic cells and
CC       in DC-residing tissues. Also found in placental macrophages,
CC       endothelial cells of placental vascular channels, peripheral blood
CC       mononuclear cells, and THP-1 monocytes.
CC       {ECO:0000269|PubMed:11257134, ECO:0000269|PubMed:11337487}.
CC   -!- DOMAIN: The tandem repeat domain, also called neck domain,
CC       mediates oligomerization.
CC   -!- POLYMORPHISM: Genetic variations in CD209 determine Mycobacterium
CC       tuberculosis susceptibility [MIM:607948].
CC   -!- POLYMORPHISM: Genetic variations in CD209 may influence
CC       susceptibility or resistance to dengue virus infection, as well as
CC       disease progression and severity [MIM:614371]. A promoter
CC       polymorphism in the CD209 gene is associated with protection from
CC       dengue fever, but not dengue hemorrhagic fever.
CC   -!- MISCELLANEOUS: In vitro, is a receptor for HIV-1 and transmits
CC       HIV-1 either in trans without DC infection, or in cis following a
CC       DC infection to permissive T-cells to induce a robust infection.
CC       Bound HIV-1 remains infectious over a prolonged period of time and
CC       it is proposed that bound HIV-1 is not degraded but protected in
CC       non-lysosomal acidic organelles within the DCs close to the cell
CC       membrane thus contributing to the HIV-1 infectious potential
CC       during transport by DCs from the periphery to lymphoid organs.
CC   -!- SIMILARITY: Contains 1 C-type lectin domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00040}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK91858.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=DC-SIGN entry;
CC       URL="http://en.wikipedia.org/wiki/DC-SIGN";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=DC-SIGN;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Ctlect_00121";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M98457; AAF77072.1; -; mRNA.
DR   EMBL; AF209479; AAG13814.1; -; Genomic_DNA.
DR   EMBL; AF290886; AAK20997.1; -; mRNA.
DR   EMBL; AY042221; AAK91846.1; -; mRNA.
DR   EMBL; AY042222; AAK91847.1; -; mRNA.
DR   EMBL; AY042223; AAK91848.1; -; mRNA.
DR   EMBL; AY042224; AAK91849.1; -; mRNA.
DR   EMBL; AY042225; AAK91850.1; -; mRNA.
DR   EMBL; AY042226; AAK91851.1; -; mRNA.
DR   EMBL; AY042227; AAK91852.1; -; mRNA.
DR   EMBL; AY042228; AAK91853.1; -; mRNA.
DR   EMBL; AY042229; AAK91854.1; -; mRNA.
DR   EMBL; AY042230; AAK91855.1; -; mRNA.
DR   EMBL; AY042231; AAK91856.1; -; mRNA.
DR   EMBL; AY042232; AAK91857.1; -; mRNA.
DR   EMBL; AY042233; AAK91858.1; ALT_SEQ; mRNA.
DR   EMBL; AK293089; BAF85778.1; -; mRNA.
DR   EMBL; AC008763; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008812; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471139; EAW68991.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW68993.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW68997.1; -; Genomic_DNA.
DR   EMBL; CH471139; EAW68998.1; -; Genomic_DNA.
DR   EMBL; BC110615; AAI10616.1; -; mRNA.
DR   CCDS; CCDS12186.1; -. [Q9NNX6-1]
DR   CCDS; CCDS45949.1; -. [Q9NNX6-7]
DR   CCDS; CCDS45950.1; -. [Q9NNX6-6]
DR   CCDS; CCDS45951.1; -. [Q9NNX6-2]
DR   CCDS; CCDS45952.1; -. [Q9NNX6-3]
DR   CCDS; CCDS59344.1; -. [Q9NNX6-8]
DR   PIR; A46274; A46274.
DR   RefSeq; NP_001138365.1; NM_001144893.1.
DR   RefSeq; NP_001138366.1; NM_001144894.1. [Q9NNX6-7]
DR   RefSeq; NP_001138367.1; NM_001144895.1. [Q9NNX6-3]
DR   RefSeq; NP_001138368.1; NM_001144896.1. [Q9NNX6-6]
DR   RefSeq; NP_001138369.1; NM_001144897.1. [Q9NNX6-2]
DR   RefSeq; NP_066978.1; NM_021155.3. [Q9NNX6-1]
DR   UniGene; Hs.278694; -.
DR   PDB; 1K9I; X-ray; 2.50 A; A/B/C/D/E/F/G/H/I/J=250-404.
DR   PDB; 1SL4; X-ray; 1.55 A; A=250-404.
DR   PDB; 1SL5; X-ray; 1.80 A; A=250-388.
DR   PDB; 2B6B; EM; 25.00 A; D=251-404.
DR   PDB; 2IT5; X-ray; 2.40 A; A=250-388.
DR   PDB; 2IT6; X-ray; 1.95 A; A=250-404.
DR   PDB; 2XR5; X-ray; 1.42 A; A=254-404.
DR   PDB; 2XR6; X-ray; 1.35 A; A=250-404.
DR   PDBsum; 1K9I; -.
DR   PDBsum; 1SL4; -.
DR   PDBsum; 1SL5; -.
DR   PDBsum; 2B6B; -.
DR   PDBsum; 2IT5; -.
DR   PDBsum; 2IT6; -.
DR   PDBsum; 2XR5; -.
DR   PDBsum; 2XR6; -.
DR   ProteinModelPortal; Q9NNX6; -.
DR   SMR; Q9NNX6; 90-127, 207-383.
DR   BioGrid; 119051; 13.
DR   DIP; DIP-60629N; -.
DR   IntAct; Q9NNX6; 2.
DR   MINT; MINT-5201078; -.
DR   STRING; 9606.ENSP00000315477; -.
DR   BindingDB; Q9NNX6; -.
DR   ChEMBL; CHEMBL1795114; -.
DR   PhosphoSite; Q9NNX6; -.
DR   BioMuta; CD209; -.
DR   DMDM; 46396012; -.
DR   REPRODUCTION-2DPAGE; Q9NNX6; -.
DR   PaxDb; Q9NNX6; -.
DR   PRIDE; Q9NNX6; -.
DR   Ensembl; ENST00000204801; ENSP00000204801; ENSG00000090659. [Q9NNX6-7]
DR   Ensembl; ENST00000315591; ENSP00000315407; ENSG00000090659. [Q9NNX6-6]
DR   Ensembl; ENST00000315599; ENSP00000315477; ENSG00000090659.
DR   Ensembl; ENST00000354397; ENSP00000346373; ENSG00000090659. [Q9NNX6-2]
DR   Ensembl; ENST00000394161; ENSP00000377716; ENSG00000090659. [Q9NNX6-4]
DR   Ensembl; ENST00000601256; ENSP00000470658; ENSG00000090659. [Q9NNX6-12]
DR   Ensembl; ENST00000601951; ENSP00000468827; ENSG00000090659. [Q9NNX6-10]
DR   Ensembl; ENST00000602261; ENSP00000471137; ENSG00000090659. [Q9NNX6-3]
DR   GeneID; 30835; -.
DR   KEGG; hsa:30835; -.
DR   UCSC; uc002mhq.2; human. [Q9NNX6-5]
DR   UCSC; uc002mhr.2; human. [Q9NNX6-10]
DR   UCSC; uc002mhs.2; human. [Q9NNX6-11]
DR   UCSC; uc002mht.2; human. [Q9NNX6-1]
DR   UCSC; uc002mhu.2; human.
DR   UCSC; uc002mhv.2; human. [Q9NNX6-6]
DR   UCSC; uc002mhx.2; human. [Q9NNX6-7]
DR   UCSC; uc010dvp.2; human. [Q9NNX6-12]
DR   UCSC; uc010dvq.2; human. [Q9NNX6-2]
DR   UCSC; uc010dvr.2; human. [Q9NNX6-4]
DR   CTD; 30835; -.
DR   GeneCards; GC19M007804; -.
DR   HGNC; HGNC:1641; CD209.
DR   HPA; CAB032436; -.
DR   HPA; CAB033831; -.
DR   MIM; 604672; gene+phenotype.
DR   MIM; 607948; phenotype.
DR   MIM; 614371; phenotype.
DR   neXtProt; NX_Q9NNX6; -.
DR   PharmGKB; PA26199; -.
DR   eggNOG; NOG311341; -.
DR   GeneTree; ENSGT00760000118924; -.
DR   HOVERGEN; HBG050992; -.
DR   InParanoid; Q9NNX6; -.
DR   KO; K06563; -.
DR   OMA; NLAKFWI; -.
DR   OrthoDB; EOG7DFXC9; -.
DR   PhylomeDB; Q9NNX6; -.
DR   TreeFam; TF333341; -.
DR   Reactome; REACT_355503; CD209 (DC-SIGN) signaling.
DR   EvolutionaryTrace; Q9NNX6; -.
DR   GeneWiki; DC-SIGN; -.
DR   GenomeRNAi; 30835; -.
DR   NextBio; 52950; -.
DR   PRO; PR:Q9NNX6; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; Q9NNX6; -.
DR   ExpressionAtlas; Q9NNX6; baseline and differential.
DR   Genevisible; Q9NNX6; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; NAS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; TAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030246; F:carbohydrate binding; NAS:UniProtKB.
DR   GO; GO:0005537; F:mannose binding; TAS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042605; F:peptide antigen binding; NAS:UniProtKB.
DR   GO; GO:0046790; F:virion binding; TAS:UniProtKB.
DR   GO; GO:0019882; P:antigen processing and presentation; NAS:UniProtKB.
DR   GO; GO:0009988; P:cell-cell recognition; TAS:UniProtKB.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; TAS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; TAS:Reactome.
DR   GO; GO:0035556; P:intracellular signal transduction; NAS:UniProtKB.
DR   GO; GO:0075733; P:intracellular transport of virus; TAS:UniProtKB.
DR   GO; GO:0007159; P:leukocyte cell-cell adhesion; NAS:UniProtKB.
DR   GO; GO:0019048; P:modulation by virus of host morphology or physiology; TAS:UniProtKB.
DR   GO; GO:0046968; P:peptide antigen transport; NAS:UniProtKB.
DR   GO; GO:0042129; P:regulation of T cell proliferation; IDA:MGI.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0019079; P:viral genome replication; NAS:UniProtKB.
DR   GO; GO:0019062; P:virion attachment to host cell; TAS:UniProtKB.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR001304; C-type_lectin.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   Pfam; PF00059; Lectin_C; 1.
DR   SMART; SM00034; CLECT; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 1.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing; Calcium;
KW   Cell adhesion; Cell membrane; Complete proteome; Disulfide bond;
KW   Endocytosis; Glycoprotein; Host-virus interaction; Immunity;
KW   Innate immunity; Lectin; Mannose-binding; Membrane; Metal-binding;
KW   Polymorphism; Receptor; Reference proteome; Repeat; Secreted;
KW   Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN         1    404       CD209 antigen.
FT                                /FTId=PRO_0000046595.
FT   TOPO_DOM      1     37       Cytoplasmic. {ECO:0000305}.
FT   TRANSMEM     38     58       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000305}.
FT   TOPO_DOM     59    404       Extracellular. {ECO:0000305}.
FT   REPEAT       96    118       1.
FT   REPEAT      119    141       2.
FT   REPEAT      142    164       3.
FT   REPEAT      165    187       4.
FT   REPEAT      188    210       5.
FT   REPEAT      211    233       6.
FT   REPEAT      234    257       7.
FT   DOMAIN      263    378       C-type lectin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00040}.
FT   REGION       96    257       7 X approximate tandem repeats.
FT   MOTIF        14     15       Endocytosis signal.
FT   MOTIF        16     18       Endocytosis signal. {ECO:0000255}.
FT   MOTIF        31     34       Endocytosis signal. {ECO:0000255}.
FT   METAL       347    347       Calcium.
FT   METAL       349    349       Calcium.
FT   METAL       351    351       Calcium; via carbonyl oxygen.
FT   METAL       354    354       Calcium.
FT   METAL       365    365       Calcium.
FT   METAL       366    366       Calcium.
FT   CARBOHYD     80     80       N-linked (GlcNAc...). {ECO:0000255}.
FT   DISULFID    256    267
FT   DISULFID    284    377
FT   DISULFID    356    369
FT   VAR_SEQ       1     15       MSDSKEPRLQQLGLL -> MASACPGSDFTSIHS (in
FT                                isoform 5, isoform 10, isoform 11 and
FT                                isoform 12).
FT                                {ECO:0000303|PubMed:11337487,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010037.
FT   VAR_SEQ      16     59       Missing (in isoform 7 and isoform 8).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010038.
FT   VAR_SEQ      30     34       GYKSL -> RNQKC (in isoform 9).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010039.
FT   VAR_SEQ      35    404       Missing (in isoform 9).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010040.
FT   VAR_SEQ      36     59       Missing (in isoform 6, isoform 10,
FT                                isoform 11 and isoform 12).
FT                                {ECO:0000303|PubMed:11337487,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_010041.
FT   VAR_SEQ      74    309       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010042.
FT   VAR_SEQ     142    233       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010043.
FT   VAR_SEQ     158    249       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010044.
FT   VAR_SEQ     191    236       Missing (in isoform 11).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010047.
FT   VAR_SEQ     301    321       NFLQLQSSRSNRFTWMGLSDL -> LQAVLEQRRAQQRWGG
FT                                RLRGI (in isoform 12).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010048.
FT   VAR_SEQ     301    306       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010049.
FT   VAR_SEQ     322    404       Missing (in isoform 12).
FT                                {ECO:0000303|PubMed:11337487}.
FT                                /FTId=VSP_010050.
FT   VARIANT     168    168       E -> D (in dbSNP:rs11465377).
FT                                /FTId=VAR_050104.
FT   VARIANT     214    214       E -> D (in dbSNP:rs11465377).
FT                                /FTId=VAR_036689.
FT   VARIANT     242    242       L -> V (in dbSNP:rs11465380).
FT                                /FTId=VAR_036690.
FT   VARIANT     382    382       A -> S (in dbSNP:rs11465393).
FT                                /FTId=VAR_050105.
FT   MUTAGEN      14     15       LL->AA: Loss of antigen internalization
FT                                by endocytosis.
FT                                {ECO:0000269|PubMed:11859097}.
FT   MUTAGEN     320    320       D->A: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   MUTAGEN     324    324       E->A: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   MUTAGEN     347    347       E->Q: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   MUTAGEN     349    349       N->D: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   MUTAGEN     350    350       N->A: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   MUTAGEN     355    355       D->A: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   MUTAGEN     365    365       N->D: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   MUTAGEN     366    366       D->A: Loss of binding to ICAM3 and HIV-1
FT                                gp120. {ECO:0000269|PubMed:11799126}.
FT   CONFLICT    152    152       W -> Q (in Ref. 4; AAK91848).
FT                                {ECO:0000305}.
FT   STRAND      261    263       {ECO:0000244|PDB:2XR6}.
FT   STRAND      266    270       {ECO:0000244|PDB:2XR6}.
FT   HELIX       277    286       {ECO:0000244|PDB:2XR6}.
FT   HELIX       297    310       {ECO:0000244|PDB:2XR6}.
FT   STRAND      314    323       {ECO:0000244|PDB:2XR6}.
FT   STRAND      326    329       {ECO:0000244|PDB:2XR6}.
FT   HELIX       337    342       {ECO:0000244|PDB:2XR6}.
FT   STRAND      356    360       {ECO:0000244|PDB:2XR6}.
FT   STRAND      363    367       {ECO:0000244|PDB:2XR6}.
FT   STRAND      373    380       {ECO:0000244|PDB:2XR6}.
FT   TURN        381    383       {ECO:0000244|PDB:2XR6}.
SQ   SEQUENCE   404 AA;  45775 MW;  A23FA246014533C0 CRC64;
     MSDSKEPRLQ QLGLLEEEQL RGLGFRQTRG YKSLAGCLGH GPLVLQLLSF TLLAGLLVQV
     SKVPSSISQE QSRQDAIYQN LTQLKAAVGE LSEKSKLQEI YQELTQLKAA VGELPEKSKL
     QEIYQELTRL KAAVGELPEK SKLQEIYQEL TWLKAAVGEL PEKSKMQEIY QELTRLKAAV
     GELPEKSKQQ EIYQELTRLK AAVGELPEKS KQQEIYQELT RLKAAVGELP EKSKQQEIYQ
     ELTQLKAAVE RLCHPCPWEW TFFQGNCYFM SNSQRNWHDS ITACKEVGAQ LVVIKSAEEQ
     NFLQLQSSRS NRFTWMGLSD LNQEGTWQWV DGSPLLPSFK QYWNRGEPNN VGEEDCAEFS
     GNGWNDDKCN LAKFWICKKS AASCSRDEEQ FLSPAPATPN PPPA
//
